Fulgent Genetics's 15min chart shows a KDJ Golden Cross, bullish Marubozu pattern.

Fulgent Genetics' 15-minute chart has recently exhibited a bullish trend, as evidenced by the KDJ Golden Cross and the formation of a Bullish Marubozu pattern at 08/18/2022 13:45. This shift in momentum suggests a potential upward trajectory for the stock price, with buyers firmly in control of the market. As a result, it is likely that the bullish momentum will continue.

Fulgent Genetics (NASDAQ: FLGT) has shown signs of a bullish trend in its 15-minute chart, with the appearance of a KDJ Golden Cross and a Bullish Marubozu pattern on August 18, 2022, at 13:45. This technical analysis suggests a shift in momentum towards an upward trajectory, with buyers currently dominating the market and bullish momentum anticipated to persist.

The KDJ Golden Cross, a technical indicator used to predict trend changes, indicates that the short-term moving average (K) has crossed above the long-term moving average (D). This pattern often signals a bullish trend, suggesting that the stock price may continue to rise. The Bullish Marubozu, characterized by a single candlestick with no lower wick and a long upper wick, further reinforces this bullish sentiment by indicating strong buying pressure.

Despite the recent earnings report for the second quarter of 2025, which showed a 15% year-over-year (YoY) increase in revenue but also a net loss of $19.0 million, the stock price has remained relatively stable. The company's full-year core revenue guidance was raised to $320 million, reflecting strong momentum in its laboratory services and therapeutic development businesses [1].

Looking ahead, Fulgent Genetics has forecasted average revenue growth of 9.0% per annum over the next three years, compared to a 6.0% industry growth forecast for the U.S. healthcare sector [1]. The technical analysis, however, indicates a bullish trend, with a KDJ Golden Cross and a Bullish Marubozu signaling an upward momentum in the stock price [4].

References:
[1] https://finance.yahoo.com/news/fulgent-genetics-second-quarter-2025-131814335.html
[2] https://www.tipranks.com/news/company-announcements/fulgent-genetics-reports-q2-2025-financial-results
[3] https://www.marketbeat.com/instant-alerts/fulgent-genetics-nasdaqflgt-shares-gap-up-after-earnings-beat-2025-08-01/
[4] https://www.investing.com/news/transcripts/earnings-call-transcript-fulgent-genetics-q2-2025-exceeds-revenue-forecast-stock-surges-93CH-4166152